OXALIPLATIN

us, european & japanese pharmacopoeia quality

FROM A RELIABLE SOURCE

OXALIPLATIN (CAS 61825-94-3) is an enantiomerically pure platinum-based antineoplastic agent (inhibition of cell proliferation) used in cancer chemotherapy.

THERAPEUTIC INDICATION: ONCOLOGY

OXALIPLATIN is used for the treatment of colorectal cancer, typically along with Folinic acid and 5-fluorouracil in a combination known as FOLFOX. It has been compared to other Pt- compounds used for advanced cancers, such as Cisplatin and Carboplatin. A combination with the mono-clonal antibody Bevacizumab increases its activity.

MARKET INFORMATION

Originator: SANOFI-AVENTIS
Originator product: ELOXATIN®

YOUR ADVANTAGES   

  • Manufactured in China by a reliable supplier
  • Good quality product with matching EP & JP quality
  • USP is based on a different process

This article uses material from Wikipedia, which is released under the Creative Commons Attribution-Share-Alike License 3.0.